Clinical Trial Protocol for the iCubate iC-GN Assay from Positive Blood Cultures: (iC-MDC-2017-001)
C
Christopher Emery, MD
Primary Investigator
Not Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study
The purpose of this study is to evaluate the performance of the iCubate Gram Negative (iC-GN) Assay in a clinical setting.
Detailed description of study
The purpose of this study is to evaluate the performance of the iCubate Gram Negative (iC-GN) Assay in a clinical setting.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Healthy,1809286430
-
Age: 100 years or below
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 1809286430
